Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 35 member G5 (SLC35G5) is a protein encoded by the SLC35G5 gene in humans[1][2][6][7]. SLC35G5 is predicted to be a multi-pass membrane transporter belonging to the SLC35 family, which primarily includes nucleotide sugar transporters[3]. It is expressed in placenta and testis[1]. The exact physiological substrate and function are uncharacterized, and it is not currently considered a therapeutic target, nor are there known disease associations or drug interactions[1][3][7]. Alternative names include AMAC1L2 and acyl-malonyl-condensing enzyme 1-like protein 2, based on sequence similarity, but these aliases do not denote established catalytic function[1][6]. No data supports involvement in major biological signaling, enzyme activity, or clinical pharmacology. If more functional/structural details become available (such as substrate specificity, transport mechanism, or disease linkage), the target may be reclassified. Current information supports its designation as an uncharacterized SLC family member, likely involved in nucleotide-sugar transport, but not yet confirmed as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 35 member G5 (SLC35G5).